We performed logistic regression analysis and found that serum levels of FGF-23 were associated with AKI (OR = 1.044, P < 0.001) (Supplementary Table 1), also related with AKI progression to CKD (OR = 1.018, P = 0.018) (Supplementary Table 2). The gene discussed is FGF23; the disease is chronic kidney disease.